During the last session, Portage Biotech Inc (NASDAQ:PRTG)’s traded shares were 2.47 million, with the beta value of the company hitting 98.81. At the end of the trading day, the stock’s price was $10.21, reflecting an intraday gain of 3.03% or $0.3. The 52-week high for the PRTG share is $58.60, that puts it down -473.95 from that peak though still a striking 79.43% gain since the share price plummeted to a 52-week low of $2.10. The company’s market capitalization is $6.84M, and the average intraday trading volume over the past 10 days was 5.49 million shares, and the average trade volume was 1.76 million shares over the past three months.
Portage Biotech Inc (PRTG) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 3.00. PRTG has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Portage Biotech Inc (NASDAQ:PRTG) trade information
Portage Biotech Inc (PRTG) registered a 3.03% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 3.03% in intraday trading to $10.21, hitting a weekly high. The stock’s 5-day price performance is 190.06%, and it has moved by 292.69% in 30 days. Based on these gigs, the overall price performance for the year is -80.74%. The short interest in Portage Biotech Inc (NASDAQ:PRTG) is 47375.0 shares and it means that shorts have 0.02 day(s) to cover.
The consensus price target of analysts on Wall Street is $19.5, which implies an increase of 47.64% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $18 and $21 respectively. As a result, PRTG is trading at a discount of -105.68% off the target high and -76.3% off the low.
Portage Biotech Inc (PRTG) estimates and forecasts
Statistics show that Portage Biotech Inc has underperformed its competitors in share price, compared to the industry in which it operates. Portage Biotech Inc (PRTG) shares have gone up 13.44% during the last six months, with a year-to-date growth rate less than the industry average at -271.05% against 17.20.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -48.08%.
PRTG Dividends
Portage Biotech Inc is due to release its next quarterly earnings in October. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Portage Biotech Inc (NASDAQ:PRTG)’s Major holders
Portage Biotech Inc insiders own 36.40% of total outstanding shares while institutional holders control 10.77%, with the float percentage being 16.93%. ARMISTICE CAPITAL, LLC is the largest shareholder of the company, while 25.0 institutions own stock in it. As of 2024-06-30, the company held over 1.5 million shares (or 7.1866% of all shares), a total value of $0.32 million in shares.
The next largest institutional holding, with 0.3 million shares, is of ‘s that is approximately 1.4247% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $71514.0.
